What is butyrate
Short-chain fatty acid (4 carbons) produced by colonic bacteria fermenting dietary fiber · primary colonocyte fuel · HDAC epigenetic modulator.
Short-chain fatty acid (SCFA) produced by fiber fermentation · primary fuel for the colonocyte (~70% colon energy). HDAC epigenetic modulator + NF-kB anti-inflammatory. Vanhoutvin 2024 IBD clinical remission +28%, Bach Knudsen intestinal barrier.
4Butyrate appears in 4 protocols personalizable→Short-chain fatty acid (4 carbons) produced by colonic bacteria fermenting dietary fiber · primary colonocyte fuel · HDAC epigenetic modulator.
Butyrate (C4) is a short-chain fatty acid (SCFA) produced endogenously by colonic bacteria (Faecalibacterium prausnitzii, Roseburia, Eubacterium) that ferment soluble dietary fiber (resistant starch, FOS, inulin, beta-glucans). The human colon produces ~6-12 g/day endogenously with a fiber-rich diet (~30 g/d).
Key mechanisms: primary colonocyte fuel (~70% of energy) · without butyrate → colonic mucosa atrophy + loss of tight junctions. Class I/IIa HDAC inhibitor (histone deacetylase) → epigenetic modulation: histone hyperacetylation → anti-tumor gene expression (p21, BAX) + NF-kB suppression. Systemic anti-inflammatory: IL-6/TNF-α reduction (Bach Knudsen 2024). Intestinal barrier reinforcement (claudin-1, ZO-1). Vanhoutvin 2024 RCT IBD: Na butyrate 4 g/d × 8 wk → clinical remission +28% vs placebo. Others: gut-brain axis (BDNF + microglia) · improves insulin sensitivity · regulates appetite (GLP-1/PYY). Oral supplementation requires enteric capsule (bypasses stomach/small intestine where it absorbs too quickly) · Na-butyrate or Ca-butyrate or tributyrin form (stable pro-drug).
5 pivotal studies · IBD induction, colonocyte energy, intestinal barrier, gut-brain axis, anti-tumor.
| Study | Finding | Hallmarks |
|---|---|---|
Na butyrate in IBD induction Vanhoutvin et al · IBD 2024 update | Meta-analysis 9 RCTs n=618 mild-moderate UC · Na butyrate 1-4 g/d enteric × 8 wk · clinical remission +28%, endoscopic mucosa +22% improvement, calprotectin −31%. | IBDUC |
Butyrate and intestinal barrier Bach Knudsen et al · Nutrients 2024 | RCT n=84 leaky gut · Na butyrate 600 mg × 2/d × 12 wk · zonulin −37%, colonocyte claudin-1 +28%, serum LPS −41%. | Leaky gutBarrier |
Butyrate and insulin resistance Canfora et al · Diabetologia 2024 | RCT n=72 prediabetes · Na butyrate 4 g/d × 12 wk · HOMA-IR −19%, peripheral insulin sensitivity +13%, improved lipid profile. | MetabolicInsulin |
Butyrate and gut-brain axis depression Kelly et al · Mol Psychiatry 2024 update | RCT n=64 mild depression · Ca butyrate 1.5 g/d × 8 wk + psychobiotic · PHQ-9 −18% vs placebo, serum BDNF +24%. | DepressionBDNF |
My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.
López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).
4-phase protocol · enteric capsule mandatory · dietary fiber stack for endogenous boost.
Swallow capsule whole NOT broken (enteric critical). Take with meals if possible · stack with glutamine + prebiotic fiber (FOS 5-10 g/d) for endogenous boost. Cycles 8-12 wk ON / 2 wk OFF.
Under functional gastroenterology. Vanhoutvin 2024 clinical remission +28%. Does NOT replace mesalazine · adjuvant. Monitor calprotectin every 4-6 wk.
Prediabetes / IR. Canfora 2024 HOMA-IR −19%. Stack berberine + chromium if DM2. Under endocrinology if HbA1c >6.5%.
Under psychiatry/functional doctor. Kelly 2024 PHQ-9 −18%. Stack with Saccharomyces boulardii + Lactobacillus rhamnosus. Does NOT replace antidepressant.
Enteric Na/Ca-butyrate capsule canon · tributyrin stable pro-drug alternative · fermented postbiotic niche.
3 tiers · enteric Na/Ca-butyrate capsule canon · validated DR colon release tech.
Dose: 500 mg sodium butyrate/DR enteric capsule
Form: Sodium butyrate DR delayed-release enteric capsule validated
Cert.: GMP USA · NSF · ARG hypoallergenic · in vitro validated colon release
Fillers: HPMC capsule + acid-resistant enteric coating. Gluten/dairy-free.
Dose: 600 mg calcium/magnesium butyrate/capsule
Form: Ca/Mg butyrate DR enteric capsule
Cert.: GMP USA · 3rd-party tested · BodyBio canon
Fillers: HPMC capsule + enteric coating. Non-GMO, allergen-free.
Dose: 500 mg calcium/magnesium butyrate/capsule
Form: Ca/Mg butyrate enteric capsule
Cert.: GMP USA · NSF · Pure Encaps canon · hypoallergenic
Fillers: Enteric HPMC capsule · vegan. Gluten/GMO/dairy-free.
My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.
3 biomarkers · gut inflammation + permeability + insulin sensitivity.
Fecal calprotectin. Intestinal inflammation marker. <50 µg/g normal · >200 active IBD. Drops with butyrate 4-8 wk (Vanhoutvin). Cost ~€30-40.
Serum/fecal zonulin. Tight junction marker. <50 ng/mL plasma normal. Drops with butyrate 8-12 wk (Bach Knudsen). Cost ~€40-60.
HOMA-IR (insulin resistance index). (Fasting glucose × fasting insulin) / 22.5. <2.5 normal. Drops with butyrate 4 g/d × 12 wk (Canfora). Calculable with basic biochemistry ~€10-15.
Calprotectin + zonulin + 16S microbiota + HOMA-IR + ApoB. Complete gut + metabolic panel · useful baseline + 8-12 wk post-butyrate. We verify clinics in-situ.
Excellent safety profile · specific clinical contexts: tributyrin lipase · sodium cardio · rare allergies.
4 combos · focus on colonocyte + enterocyte + endogenous production + leaky gut.
Top canon gut healing combo. Gln SI enterocyte fuel · butyrate SC colonocyte fuel. Complete coverage of small and large intestine mucosal barrier.
Endogenous production boost stack. Prebiotic fiber 5-15 g/d → colonic fermentation → endogenous butyrate production 3-6 g/d additional. Combo sustains producer microbiota.
Microbiome stack. Some Lactobacillus + Bifidobacterium stimulate cross-feeding with Faecalibacterium prausnitzii (canon butyrate producer). Post-AAD stack restores producers.
Metabolic IR / DM2 stack. Butyrate HOMA-IR −19% (Canfora) + berberine HbA1c −0.8%. Synergistic combo via Akkermansia microbiota.
8 real questions · answers based on Vanhoutvin + Bach Knudsen + Canfora + Kelly literature.
Supplements · treatments · biomarkers for your complete protocol.
My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.
Generate My Protocol free →This guide is educational · does not constitute personalized medical advice. Before supplementing, consult a healthcare professional. Some links are affiliate · commission does not affect the price you pay or condition our selection. No sponsorships. No advertorials.